📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

BCL-3 loss sensitises colorectal cancer cells to DNA damage by targeting homologous recombination. (2022)

First Author: Parker C

Attributed to: Does aspirin increase the clinical response to pre-operative chemo-radiotherapy [CRT] in rectal cancer? funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.dnarep.2022.103331

PubMed Identifier: 35468497

Publication URI: http://europepmc.org/abstract/MED/35468497

Type: Journal Article/Review

Volume: 115

Parent Publication: DNA repair

ISSN: 1568-7856